참고문헌
- Robertson MC, Cosby H, Fresnoza A, Cattini PA, Shiu RP, Friesen HG. Expression, purification, and characterization of recombinant rat placental lactogen-I: a comparison with the native hormone. Endocrinology 1994; 134: 393-400 https://doi.org/10.1210/en.134.1.393
- Deb S, Faria TN, Roby KF, Larsen D, Kwok SC, Talamantes F, Soares MJ. Identification and characterization of a new member of the prolactin family, placental lactogen-I variant J Bioi Chern 1991; 266: 1605-1610
- Duckworth ML, Kirk KL, Friesen HG. Isolation and identification of a cDNA clone of rat placental lactogen II. J Bioi Chern 1986; 261: 10871-10878
- Campbell WJ, Deb D, Kwok SCM, Joslin JA, Soares:MJ. Differential expression of placental lactogen-II and prolactin-like protein-A in the rat chorioallantoic placenta. Endocrinology 1989; 125: 1565-1574 https://doi.org/10.1210/endo-125-3-1565
- Duckworth ML, Schroedter IC, Friesen HG. Cellular localization of rat placental lactogen II and rat prolactin-like proteins A and B by in situ hybridization. Placenta 1990; 11: 143-155 https://doi.org/10.1016/S0143-4004(05)80176-6
- Duckworth ML, Peden LM, Friesen HG. Isolation of a novel prolactin-like cDNA clone from developing rat placenta. J Bioi Chern 1986; 261: 10879-10884
- Croze F, Kennedy TG, Schroedter IC, Friesen HG. Expression of rat prolactin like protein B in deciduoma of pseudopregnant rat and in decidua during early pregnancy. Endocrinology 1990; 127: 2665-2672 https://doi.org/10.1210/endo-127-6-2665
- Deb S, Roby KF, Faria TN, Szpirer C, Levan G, Kwok SCM, Soares MJ. Molecular cloning and characterization of prolactin-like protein C complementary deoxyribonucleic acid. J Biol Chern 1991; 266: 23027-23032
- Dai G, Liu B, Szpirer C, Levan G, Kwok SC, Soares MJ. Prolactin-like protein-C variant: complementary deoxyribonucleic acid, unique six exon gene structure, and trophoblast cell-specific expression. Endocrinology 1996; 137: 5009-5019 https://doi.org/10.1210/en.137.11.5009
- Iwatsuki K, Shinozaki M, Hattori N, Hirasawa K, ltagaki S, Shiota K, Ogawa T. Molecular cloning and characterization of a new member of the rat placental prolactin (PRL) family, PRL-like protein D (PLP-D). Endocrinology 1996; 137: 3849-3855 https://doi.org/10.1210/en.137.9.3849
- Roby KF, Deb S, Gibori G, Szpirer C, Levan G, Kwok SCM, Soares MJ. Decidual prolactin-related protein. J Bioi Chem 1993; 268: 3136-3142
- Ishibashi K, lmai M.Identification of four new members of the rat prolactin/growth hormone gene family. Biochem Biophys Res Commun 1999; 262: 575-578 https://doi.org/10.1006/bbrc.1999.1260
- Toft DJ, Linzer DI. Prolactin (PRL)-like protein J, a novel member of the PRL/ growth hormone family, is exclusively expressed in maternal decidua. Endocrinology 1999; 140: 5095-5101 https://doi.org/10.1210/en.140.11.5095
- Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR,Simmons DM, Swanson L, Rosenfeld MG. A tissuespecific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988; 55: 519-529 https://doi.org/10.1016/0092-8674(88)90038-4
- Karin M, Theill L, Castrillo JL, McCormick A, Brady H. Tissue-specific expression of the growth hormone gene and its control bygrowth hormone factorl. Recent Prog Horm Res 1990; 46:43-57
- Haugen BR, Wood WM, Gordon DF, Ridgway EC. A thyrotrope-specific variant of Pit-1 transactivates the thyrotropin beta promoter. J Bioi Chern 1993; 268: 20818-20824
- Ruvkun G, Finney M. Regulation of transcription and cell identity by POU domain proteins. Cell 1991; 64: 475-478 https://doi.org/10.1016/0092-8674(91)90227-P
- Bodner M, Karin M. A pituitary-specifictrans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 1987; 50: 267-275 https://doi.org/10.1016/0092-8674(87)90222-4
- Li S, Crenshaw EB 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990; 347: 528-533 https://doi.org/10.1038/347528a0
- Bamberger AM, Bamberger CM,Pu LP, Puy LA, Loh YP,Asa SL. Expression of pit-1 messenger ribonucleic acid and protein in the human placenta. J Clin Endocrinol Metab 1995; 80: 2021-2026 https://doi.org/10.1210/jc.80.7.2021
- Lee BJ, Jeong JK, Kim JH, Kang SG, Kim MO, Choi WS. Local expression of a POU family transcription factor, Pit-1, in the rat placenta. Mol Cell Endocrinol 1996; 118: 9-14 https://doi.org/10.1016/0303-7207(95)03758-6
- Lee CK, Kang HS, Lee BJ, Kang HM, Chill WS, Kang SG. Effects of dopamine and melatonin on the regulation of the PIT-1 isotype, placental growth hormone and lactogen gene expressions in the rat placenta. Mol Cells 1999; 9: 646-651
- Lee CK, Kang HS, Lee BJ, Kang HM, Choi WS, Kang SG. Effects of dopamine and estrogen on the regulation of Pit-1 alpha, Pit-1 beta, and PL-II gene expression in the rat placenta. Mol Cells 1998; 8: 205-211
- Donaldson DL, Rennert OM. Chromium (III) metabolism by the kidney. Ann Clin Lab Sci 1981; 11: 377-385
- Ding M,Shi X, Castranova V,Vallyathan V. Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J Environ Pathol Toxicol Oncol 2000; 19: 129-138
- Gibb HJ, Lees PS, Pinsky PF, Rooney BC. Lung cancer among workers in chromium chemical production. Am J lnd Med 2000; 38: 115-126 https://doi.org/10.1002/1097-0274(200008)38:2<115::AID-AJIM1>3.0.CO;2-Y
- Fleet JC, Golemboski KA, Dietert RR, Andrews GK, McCormick Ce. Induction of hepatic metallothionein by intraperitoneal metal injection: an associated inflammatory response. Am J Physiol 1990; 258: 926-933
- Solis-Heredia MJ, Quintanilla-Vega B, Sierra-Santoyo A, Hernandez JM, Brambila E, Cebrian ME, Albores A. Chromium increases pancreatic metallothionein in the rat. Toxicology 2000; 142: 111-117 https://doi.org/10.1016/S0300-483X(99)00130-4
- Goyer RA, Haust MD, Cherian MG. Cellular localization of metallothionein in human term placenta. Placenta 1992; 13: 349-355 https://doi.org/10.1016/0143-4004(92)90059-3
- Cheng L, Sountag DM, de BoerJ, Dixon K. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J Environ Pathol Toxicol Oncol 2000; 19: 239-249
- D'Agostini F, Izzotti A, Bennicelli C, Camoirano A, Tampa E, De Bora S. Induction of apoptosis in thelungbutnot in theliverof ratsreceiving intra-tracheal instillations of chromium(VI). Carcinogenesis 2002; 23:587-593 https://doi.org/10.1093/carcin/23.4.587
- Pritchard DE,Ceryak S,Ha L,Fornsaglio JL,Hartman SK, O'Brien TJ, Patierno SR. Mechanism of apoptosis and determination of cellular fate in chromium(VI)exposed populations of telomeraseimmortalized human fibroblasts. Cell Growth Difjer2001; 12: 487-496
- Vasant C, Balamurngan K, Rejaram R, Ramasami T. Apoptosis of lymphocytes in the presence of Cr(V) complexes: role in Cr(VI)-induced toxicity. Biochem Biophys Res Commun 2001; 285: 1354-1360 https://doi.org/10.1006/bbrc.2001.5335
- Travacio M, Polo JM, Llesuy S. Chromium (VI) induces oxidative stress in the mouse brain. Toxicology 2001; 162: 139-148 https://doi.org/10.1016/S0300-483X(00)00423-6
- Zhang Z, Leonard SS, Wang S, Vallyathan V, Castranova V, Shi X. Cr (VI) induces cell growth arrest through hydrogen peroxide-mediated reactions. Mol Cell Biochem 2001; 222: 77-83 https://doi.org/10.1023/A:1017963307358
- Kanojia RK, Junaid M, Murthy RC. Chromium induced teratogenecity in female rat. Toxicol Lett 1996; 89: 207-213 https://doi.org/10.1016/S0378-4274(96)03812-X
- Kanojia RK, Junaid M, Murthy RC. Embryo and fetotoxicity of hexavalent chromium: a long-term study. Toxicol Lett 1998; 95: 165-172
- Thordarson G, Galosy S, Gudmundsson GO, Newcomer B, Sridaran R, Talamantes F. Interaction of mouse placental lactogens and androgens in regulating progesterone release in cultured mouse luteal cells. Endocrinology 1997; 138: 3236-3241 https://doi.org/10.1210/en.138.8.3236
- Galosy SS, Talamantes F. Luteotropic actions of placental lactogens at midpregnancy in the mouse. Endocrinology 1995; 136: 3993-4003 https://doi.org/10.1210/en.136.9.3993
- Yamaguchi M, Endo H, Thordarson G, Ogren L, Talamantes F. Modulation of mouse placental lactogen-I secretion in vitro: effects of progesterone and mouse placental lactogen-II. Endocrinology 1992;130:2897-2905 https://doi.org/10.1210/en.130.5.2897
- Forsyth IA. Comparative aspects of placental lactogens: structure and function. Exp Clin Endocrinol 1994; 102: 244-251 https://doi.org/10.1055/s-0029-1211288
- Telleria CM,Zhong L, Deb S, Srivastava RK, Park KS, Sugino N, Park-Sarge OK, Gibori G. Differential expression of the estrogen receptors alpha and beta in the rat corpus luteum of pregnancy: regulationby prolactin and placentallactogens. Endocrinology 1998; 139: 2432-2442 https://doi.org/10.1210/en.139.5.2432
- Cohick CB, Dai G, Xu L, Deb S, Kemei T, Levan G, Szpirer C, Szpirer J, Kwok SC, Soares MJ. Placental lactogen-I variant utilizes the prolactin receptor signaling pathway. Mol Cell Endocrinol 1996; 116: 49-58 https://doi.org/10.1016/0303-7207(95)03695-4
- Muller H,Liu B,Croy BA, Head JR,Hunt JS, Dai G, Soares MJ. Uterine natural killer cells are targets for a trophoblast cell-specific cytokine, prolactin-like protein A. Endocrinology 1999; 140: 2711-2720 https://doi.org/10.1210/en.140.6.2711
- Ma GT, Linzer DI. GATA-2 restricts prolactin-like protein A expression to secondary trophoblastgiant cells in the mouse. Bioi Reprod 2000; 63: 570-574 https://doi.org/10.1095/biolreprod63.2.570
- Rasmussen CA, Orwig KE, Vellucci S, Soares :MJ. Dual expression of prolactinrelated protein in decidua and trophoblast tissues during pregnancy in rats. Bioi Reprod 1997; 56: 647-654 https://doi.org/10.1095/biolreprod56.3.647
- Conliffe PR, Simmen RC, Buhi WC, Shiverick KT. Cloning of a novel rat placental prolactin-like protein C-related cDNA. Mol Reprod Dev 1995; 41: 167-176 https://doi.org/10.1002/mrd.1080410207
- Elsholtz HP, Lew AM, Albert PR, Sundmark VC. Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene. J Bioi Chern 1991; 266: 22919-22925
- Pattison DI, Davies MJ, Levina A, Dixon NE, Lay PA. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity. Chem ResToxieol 2001; 14: 500-510
- Pattison DI, Lay PA, Davies MJ. EPR studies of chromium(V) intermediates generated via reduction of chromium(VI) by DOPA and related catecholamines: potential role for oxidized amino acids in chromium-induced cancers. Inorg Chern 2000; 39: 2729-2739 https://doi.org/10.1021/ic991443a
- Shainkin-Kestenbaum R, Caruso C, Berlyne GM. Effect of chromium on oxygen free radical metabolism, inhibition of superoxide dismutase and enhancement of 6-hydroxydopamine oxidation. J Trace Elem Electrolytes HealthDis 1991; 5: 197-201
- Matuszyk J, Kalas W, Cebrat M, Strzadala L. High expression of endogenous bel-2 and bcl-xL.in thymic lymphomas do not diminish their sensitivity to etoposideinduced apoptosis. Anticancer Res2001; 21:2677-2680
- Schimmer AD, Hedley DW, Pham NA, Chow S, Minden :MD. BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL withoutloss of mitochondrial membrane potential. Leuk Lymphoma 2001; 42:429-443 https://doi.org/10.3109/10428190109064600
- Sundararajan R, Cuconati A, Nelson D, White E. Tumor Necrosis Factor-alpha Induces Bax-Bak Interaction and Apoptosis, WhichIs Inhibited by Adenovirus ElB 19K. J Bioi Chern 2001; 276: 45120-45127 https://doi.org/10.1074/jbc.M106386200
- Huh WK, Gomez-Navarro J, Arafat WO, Xiang J, Mahasreshti PJ, Alvarez RD, Barues MN, Curiel DT. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix. Gynecol Oncol 2001; 83: 370-377 https://doi.org/10.1006/gyno.2001.6403
- Stohs SJ, Bagchi D, HassounE, Bagchi M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J Environ Pathol Toxicol Oncol 2001; 20: 77-88
- Powlin SS,Keng PC, Miller RK.Toxicity of cadmiumin human trophoblast cells (JAr choriocarcinoma): role of calmodulin and the calmodulin inhibitor, zaldaride maleate. Toxicol Appl Pharmacol 1997; 144: 225-234 https://doi.org/10.1006/taap.1997.8135
- McAleer MF, Tuan RS. Metallothionein protects against severe oxidative stressinduced apoptosis of human trophoblastic cells. In VilT Mol Toxieol 2001; 14: 219-231
- McAleer MF, Tuan RS. Metallothionein overexpression in human trophoblastic cells protects against cadmium-induced apoptosis In Vitr Mol Toxieol 2001; 14: 25-42 https://doi.org/10.1089/109793301316882522
- Junaid M, Murthy RC, Saxena DK. Bmbryotoxicity of orally administered chromium in mice: exposure during the period of organogenesis. Toxicol Lett 1966; 84: 143-148 https://doi.org/10.1016/0378-4274(95)03607-5